Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Technology Industry News Wipro partners with DataRobot for scalable enterprise AI solutions Wipro has entered into a partnership with augmented intelligence provider DataRobot with an objective to expedite the operationalization… byPallavi MadhirajuAugust 27, 2021
